Clinical Trials Directory

Trials / Sponsors / Elixir Medical Corporation

Elixir Medical Corporation

Industry · 18 registered clinical trials1 currently recruiting.

StatusTrialPhaseStarted
RecruitingDynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor
Coronary Artery Disease
2024-03-10
CompletedA Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Cathe
Coronary Artery Disease
N/A2023-04-27
Active Not RecruitingThe DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronar
Coronary Artery Disease
Phase 22021-12-15
UnknownDYNAMX Bioadaptor ImplanTation for the trEatment of Complex Coronary Lesions
Coronary Artery Disease, Chronic Total Occlusion of Coronary Artery, Bifurcation of Coronary Artery
N/A2021-10-19
Active Not RecruitingThe Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries
Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease
N/A2020-12-16
Active Not RecruitingInfinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
Coronary Artery Disease, Ischemic Heart Disease
N/A2020-09-30
CompletedDynamX Bioadaptor Hong Kong Registry
Coronary Artery Disease
Phase 42020-09-30
TerminatedDESyne X2 Post Market Follow-up Study
Coronary Artery Disease
N/A2020-09-01
CompletedDynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System
Coronary Artery Disease
N/A2018-12-10
CompletedEvaluation of a Thin Strut Metallic Stent: the Elixir DynamX Clinical Study
Coronary Artery Disease
N/A2017-11-16
CompletedThe DESappear Study: Drug Eluting Scaffold
Peripheral Vascular Disease
N/A2016-10-10
CompletedElixir Medical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - Cx Regist
Coronary Artery Disease
N/A2016-01-20
TerminatedDESolve® X-Pand Global Post Market Registry
Coronary Artery Stenosis
2015-05-13
CompletedDESolve Post-Approval Study
Coronary Artery Disease
N/A2014-04-22
CompletedEXCELLA Post-Approval Study
Coronary Artery Disease
N/A2014-02-26
CompletedElixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System -
Coronary Artery Disease
N/A2011-11-01
CompletedElixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESol
Coronary Artery Disease
N/A2011-02-01
CompletedElixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA
Coronary Artery Disease
N/A2008-10-01